You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雙成藥業(002693.SZ):擬將擁有的醋酸曲普瑞林注射液相關權利轉讓予萊美藥業

格隆匯8月1日丨雙成藥業(002693.SZ)公佈,公司(“甲方”)於2022年8月1日召開第四屆董事會第二十八次會議,會議審議通過了《關於公司簽署<產品權利轉讓協議>的議案》,同意公司擬與重慶萊美藥業股份有限公司(簡稱“萊美藥業”、“乙方”)和杭州博盈健康科技有限公司(簡稱“杭州博盈”、“丙方”)簽署《產品權利轉讓協議》,合同金額人民幣3200萬元。公司擬將擁有與醋酸曲普瑞林注射液(以下簡稱“轉讓產品”、“該產品”)有關的所有的有形與無形資產、權利在指定區域內授予萊美藥業。

醋酸曲普瑞林注射液適用於不育治療下所需的垂體降調節(例如:體外授精術(IVF)、配子輸卵管內移植(GIFT)和無輔助治療方法的促卵泡成熟等)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account